(Q37811998)

23 August 2017

title

Resistant hypertension and sleep apnea: pathophysiologic insights and strategic management (English)

1 reference

23 August 2017

main subject

arterial hypertension

0 references

1 reference

1 reference

1

0 references

James A Underberg

series ordinal

5

0 references

Girardin Jean-Louis

series ordinal

3

0 references

Gbenga Ogedegbe

series ordinal

7

object named as

Gbenga Ogedegbe

1 reference

23 August 2017

4

Ferdinand Zizi

1 reference

23 August 2017

6

Samy I McFarlane

1 reference

23 August 2017

2

Joseph Ravenell

1 reference

23 August 2017

publication date

1 February 2011

1 reference

23 August 2017

published in

Current diabetes report

1 reference

23 August 2017

volume

11

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

64-69

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

23 August 2017

1 reference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Prospective study of the association between sleep-disordered breathing and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Sleep apnea and systemic hypertension: a causal association review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

High prevalence of cardiac and extracardiac target organ damage in refractory hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Positive effect of CPAP treatment on the control of difficult-to-treat hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

21 January 2018

Sleep and Hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Counc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

The occurrence of sleep-disordered breathing among middle-aged adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

High prevalence of unrecognized sleep apnoea in drug-resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Pathophysiology of sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

The sympathetic nervous system and obstructive sleep apnea: implications for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Obstructive sleep apnea and cardiac index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Renin activity and blood pressure in response to chronic episodic hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Hypoxia induces endothelin gene expression and secretion in cultured human endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Independent association of drug-resistant hypertension to reduced sleep duration and efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Clinical practice. Resistant or difficult-to-control hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

The effect of correction of sleep-disordered breathing on BP in untreated hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

A double-blind, crossover study of Doxazosin and Enalapril on peripheral vascular tone and nocturnal blood pressure in sleep apnea patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Angiotensin-converting enzyme inhibitors and obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

Effect of revised UPPP surgery on ambulatory BP in sleep apnea patients with hypertension and oropharyngeal obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

The diurnal blood pressure profile. A population study

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

21 January 2018

12 December 2020

High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0161-Z

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

21 January 2018

1 reference

12 December 2020

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group

1 reference

12 December 2020

Sleep apnea syndrome: a possible contributing factor to resistant

1 reference

12 December 2020

Hypertension caused by chronic intermittent hypoxia--influence of chemoreceptors and sympathetic nervous system

1 reference

12 December 2020

Influence of metoprolol and cilazapril on blood pressure and on sleep apnea activity

1 reference

12 December 2020

Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults

1 reference

12 December 2020

Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial

1 reference

12 December 2020

Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study

1 reference

12 December 2020

Obstructive sleep apnea and hypertension

1 reference

12 December 2020

Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk.

1 reference

12 December 2020

Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea.

1 reference

12 December 2020

Population-based study of sleep-disordered breathing as a risk factor for hypertension

1 reference

12 December 2020

Combined hypoxia and hypercapnia evokes long-lasting sympathetic activation in humans

1 reference

12 December 2020

Effect of spironolactone on blood pressure in subjects with resistant hypertension

1 reference

12 December 2020

Dippers and non-dippers

1 reference

12 December 2020

10.1007/S11892-010-0161-Z

Identifiers

DOI

1 reference

23 August 2017

1 reference